Xenon Pharmaceuticals Cash Flow Statement (2013-2026) | XENE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)	-15.45M	-27.60M	-19.67M	-31.16M	-37.15M	-37.44M	-41.73M	-47.46M	-48.46M	-44.74M	-47.93M	-57.92M	-62.79M	-65.69M	-65.05M	-84.71M	-90.90M	-114.63M	-102.30M	-110.74M
Share-based Compensation (Quarter)	2.64M	2.71M	3.61M	5.21M	5.74M	-11.54M	5.99M	8.45M	8.74M	9.18M	9.40M	14.72M	13.00M	-37.07M	12.17M	13.71M	13.71M	14.12M	16.89M	124.94M
Deferred Taxes (Quarter)	-0.27M	0.35M	0.26M	-0.10M	-0.20M	0.01M	0.29M	-0.22M	-0.16M	-0.20M	0.40M	-0.33M	-0.32M	-8.61M	-1.21M	-0.17M	-0.70M	-1.11M	0.45M	-1.94M
Cash from Operations (Quarter)	-15.01M	-20.71M	-18.43M	-16.87M	-30.40M	-35.33M	-34.41M	-33.22M	-48.08M	-35.40M	-46.19M	-31.15M	-49.66M	-54.38M	-61.65M	-64.23M	-71.75M	-81.48M	-88.90M	-95.39M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization of Deferred Charges (Quarter)											0.31M	0.31M	0.32M	0.32M	0.32M	0.33M	0.33M	0.33M	0.34M	0.33M
Depreciation & Amortization (CF) (Quarter)	0.21M	0.27M	0.38M	0.38M	0.36M	0.30M	0.35M	0.60M	1.73M	-0.63M	0.59M	0.64M	0.67M	0.67M	0.66M	0.63M	0.64M	0.61M	0.59M	0.56M
Change in Working Capital
Change in Receivables (Quarter)	0.33M	-0.48M	0.15M	-0.39M	-0.01M	-1.51M	-0.23M	-0.04M	-0.15M	0.29M	-0.04M	0.02M	0.08M	0.55M	7.18M
Change in Accured Expenses (Quarter)	-1.27M	3.76M	-5.80M	5.79M	2.06M	6.02M	-0.59M	5.58M	-3.36M	2.30M	-5.02M	9.15M	-1.79M	6.18M	-3.78M	0.87M	6.07M	2.35M	-1.80M	5.72M
Other Working Capital Changes (Quarter)	-0.82M	-2.20M				-0.60M					-0.30M	-0.29M	-0.31M	-0.32M	-0.31M	-0.32M	-0.34M	-0.34M	-0.35M	-0.36M
Investing Activities
Capital Expenditures (Quarter)	0.22M	0.51M	0.21M	0.54M	0.39M	1.75M	2.21M	2.13M	1.20M	0.08M	0.19M	1.51M	0.59M	0.78M	0.04M	0.16M	0.28M	0.32M	0.13M	0.28M
Change in Acquisitions & Divestments (Quarter)	25.80M	42.27M	20.28M	74.54M	61.04M	104.76M	157.11M	192.31M	201.85M	136.88M	133.84M	235.68M	165.18M	165.64M	165.79M	171.23M	113.51M	123.92M	98.50M	159.42M
Cash from Investing Activities (Quarter)	15.57M	-215.43M	-48.89M	1.32M	-234.10M	-11.74M	46.62M	27.90M	53.88M	-239.79M	-43.19M	109.19M	0.50M	98.50M	34.51M	82.26M	38.53M	62.70M	-407.28M	-331.24M
Financing Activities
Other financing activities (Quarter)	0.03M	0.01M				0.01M								0.05M	1.15M	0.07M	2.36M	1.39M	5.49M	0.03M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	5.92M	5.64M	7.08M	7.23M	3.39M	7.12M	4.10M	8.68M	4.62M	8.89M	10.68M	10.78M	5.98M	10.71M	6.55M	6.29M	11.18M	11.07M	5.68M	11.81M
Net Equity Issued and Repurchased (Quarter)			7.88M						29.51M
Misc.
Cash from Financing Activities (Quarter)	4.76M	323.95M	7.88M	269.89M	0.70M	0.01M				324.01M				12.13M	1.15M	0.07M	2.36M	113.54M	843.01M	0.03M
Exchange Rate Effect (Quarter)	-0.45M	0.07M	0.29M	-0.89M	-2.70M	0.81M	0.06M	0.36M	-0.29M	0.25M	-0.37M	-0.20M	0.05M	-1.16M	-0.06M	0.63M	-0.01M	-0.10M	-0.13M	0.26M
Change in Cash (Quarter)	4.88M	87.88M	-59.15M	253.45M	-266.50M	-46.25M	12.27M	-4.96M	35.02M	49.07M	-89.75M	77.84M	-49.11M	55.09M	-26.05M	18.72M	-30.87M	94.65M	346.70M	-426.34M
Free Cash Flow (Quarter)	-15.23M	-21.22M	-18.64M	-17.41M	-30.79M	-37.08M	-36.62M	-35.35M	-49.28M	-35.48M	-46.38M	-32.67M	-50.26M	-55.17M	-61.70M	-64.39M	-72.03M	-81.80M	-89.03M	-95.67M
Net Cash Flow (Quarter)	5.33M	87.81M	-59.44M	254.34M	-263.80M	-47.06M	12.21M	-5.32M	5.80M	48.82M	-89.38M	78.04M	-49.17M	56.25M	-25.99M	18.09M	-30.86M	94.75M	346.83M	-426.60M

Research Tools

Datasets

Plans

Developers

Xenon Pharmaceuticals Cash Flow Statement (2013-2026) | XENE

Research Tools

Datasets

Plans

Developers

Xenon Pharmaceuticals Cash Flow Statement (2013-2026) | XENE

Create an account

Sign In

Reset Password